CN116406678A - Spray for blocking new coronavirus, preparation method and application thereof - Google Patents
Spray for blocking new coronavirus, preparation method and application thereof Download PDFInfo
- Publication number
- CN116406678A CN116406678A CN202111665386.4A CN202111665386A CN116406678A CN 116406678 A CN116406678 A CN 116406678A CN 202111665386 A CN202111665386 A CN 202111665386A CN 116406678 A CN116406678 A CN 116406678A
- Authority
- CN
- China
- Prior art keywords
- powder
- spray
- vitamin
- eucommia ulmoides
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007921 spray Substances 0.000 title claims abstract description 56
- 241000711573 Coronaviridae Species 0.000 title claims abstract description 45
- 230000000903 blocking effect Effects 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 68
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 38
- 241000208689 Eucommia ulmoides Species 0.000 claims abstract description 28
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 23
- 241000235395 Mucor Species 0.000 claims abstract description 20
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 19
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000011709 vitamin E Substances 0.000 claims abstract description 19
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 19
- 229940046009 vitamin E Drugs 0.000 claims abstract description 19
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 18
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 13
- 239000008103 glucose Substances 0.000 claims abstract description 13
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 13
- 241000251468 Actinopterygii Species 0.000 claims abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 9
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 6
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 6
- 229960002477 riboflavin Drugs 0.000 claims abstract description 6
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 6
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims description 15
- 229940088594 vitamin Drugs 0.000 claims description 12
- 229930003231 vitamin Natural products 0.000 claims description 12
- 235000013343 vitamin Nutrition 0.000 claims description 12
- 239000011782 vitamin Substances 0.000 claims description 12
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 12
- 238000000855 fermentation Methods 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 239000011812 mixed powder Substances 0.000 claims description 10
- 239000002002 slurry Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 241000235388 Mucorales Species 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 238000010025 steaming Methods 0.000 claims description 5
- 150000003384 small molecules Chemical class 0.000 claims description 3
- 230000009471 action Effects 0.000 abstract description 5
- 230000002779 inactivation Effects 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 2
- 235000019688 fish Nutrition 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 description 20
- 241000700605 Viruses Species 0.000 description 19
- 241000282414 Homo sapiens Species 0.000 description 15
- 230000000694 effects Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 230000000415 inactivating effect Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010061418 Zygomycosis Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 201000007524 mucormycosis Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
- A01N25/10—Macromolecular compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/10—Animals; Substances produced thereby or obtained therefrom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/30—Microbial fungi; Substances produced thereby or obtained therefrom
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Epidemiology (AREA)
- Agronomy & Crop Science (AREA)
- Microbiology (AREA)
- Pest Control & Pesticides (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
Abstract
The invention provides a spray for blocking new coronaviruses, a preparation method and application thereof, and relates to the technical field of biological medicines. The spray provided by the invention is prepared from the following raw materials: mucor powder, soybean protein powder, glucose powder, isomaltooligosaccharide, vitamin B2, vitamin E, fish skin peptide powder, eucommia ulmoides leaf juice and small molecular water. The spray prepared by the invention can safely and effectively block and inactivate the novel coronavirus, the inactivation rate reaches more than 99 percent, and the action time is long. In addition, the preparation method provided by the invention is simple and easy to operate, and is suitable for industrial mass production.
Description
Technical field:
the invention relates to the technical field of biological medicine, in particular to a spray for blocking new coronaviruses, a preparation method and application thereof.
The background technology is as follows:
the spray and the application of the spray are active protection products for blocking new coronaviruses, the design concept of the spray and the application of the spray is derived from human vaccines, the names are different, the purpose of preventing viruses is the same, and the spray and the application of the spray are innovations based on the vaccines. Vaccine discovery is a milestone-like event in the history of human development. In a sense, the history of human reproduction is the history of continuous disease and natural disaster fight of humans, the most important means of controlling infectious diseases is prevention, and vaccination is considered the most effective means. The fact proves that the smallpox virus threatening human beings for hundreds of years is thoroughly destroyed after the occurrence of vaccinia epidemic, and the first victory of human beings against the virus with the vaccine is more convinced that the vaccine has the effect of controlling and eliminating infectious diseases. The vaccine family has been expanding and developed over 200 years later, and more than 20 vaccines for preventing and treating human diseases are currently available.
It is known that vaccination has a major role in preventing human infection with virus, requiring clinic and long time, and large development cost, and that vaccines make a great contribution to human health, but vaccines need to be injected into human body, there are more or less uncertain factors and potential safety hazards, such as new coronavirus vaccines worldwide, the biggest pharmaceutical companies worldwide, developed new coronavirus vaccines have been used in batches, but allergy and side effects of new coronavirus vaccines in experiments, and immune deficiency people such as children, cancer patients, organ transplantation, pregnant women, aids patients, whether or not they can be vaccinated, which people can meet seeds, and the like, become problems and choices faced by people. The effective time of the vaccine, potential risk, unknown side effects, etc., require a significant amount of time and time for human use to find an answer. In addition, the production time varies from vaccine to vaccine, and some vaccines even require approximately 2 years to produce a batch. Vaccine development is a lengthy and complex process and is costly. The speed of vaccine development never goes up to the speed of virus variation.
It is well known that all viruses are derived from the environment where the nature exists, and human vaccines are developed after the viruses are found, and the viruses belong to passive prevention, and are difficult to treat both symptoms and root causes. The spraying and applying spray is to spray in public places and living rooms in advance when viruses are not found, so that the viruses can be driven and effectively inactivated, the viruses are hidden everywhere, and the method belongs to active prevention. The spray does not need to be injected into a human body, only needs to treat the indoor environment and is stuck to a certain part of the body, integrates the effectiveness, the safety, the timeliness and the flexibility, and can make up the defects of various uncertain factors of human vaccines.
The invention comprises the following steps:
the invention aims to provide a spray for blocking new coronaviruses, a preparation method and application thereof. The spray prepared by the invention can safely and effectively block and inactivate the novel coronavirus, and has long action time.
The invention provides a spray for blocking new coronaviruses, which is prepared from the following raw materials: 0.1-0.5kg of mucor powder, 70-100kg of soybean protein powder, 100-200kg of glucose powder, 1-2kg of isomaltooligosaccharide, 0.1-0.3kg of vitamin B, 0.05-0.2kg of vitamin E, 0.05-0.3kg of fishskin peptide powder, 0.1-0.5kg of eucommia ulmoides leaf juice and 50-60kg of micromolecular water.
Preferably, the weight ratio of the mucorales powder to the vitamin E is 2-6:1; more preferably, the weight ratio of mucorales powder to vitamin E is 4:1.
Preferably, the spray is prepared from the following raw materials: mucor powder 0.4kg, soybean protein powder 80kg, glucose powder 150kg, isomaltooligosaccharide 1.6kg, vitamin B2.2 kg, vitamin E0.1 kg, fish skin peptide powder 0.22kg, eucommia ulmoides leaf juice 0.4kg, and small molecule water 58kg.
The invention also provides a preparation method of the spray, which comprises the following steps:
(1) Taking soybean protein powder according to the weight, steaming, and naturally cooling to room temperature; taking fresh eucommia ulmoides leaves, cleaning, crushing and juicing to obtain eucommia ulmoides leaf juice for later use;
(2) Adding mucor powder into the soybean protein powder obtained in the step (1) according to the weight, uniformly stirring, naturally fermenting for 7 days, crushing into slurry, and filtering;
(3) Taking eucommia ulmoides leaf juice according to the weight, adding the eucommia ulmoides leaf juice into the filtered slurry obtained in the step (2), naturally fermenting for 7 days again, and extracting and purifying at normal temperature to obtain fermentation liquor;
(4) Mixing glucose powder, vitamin B2, vitamin E, isomaltooligosaccharide and fish skin peptide powder according to weight, grinding for 6-8h to 20-30nm to obtain mixed powder;
(5) Taking small molecular water according to the weight, adding the mixed powder obtained in the step (4) into the small molecular water, uniformly mixing, adding the fermentation broth obtained in the step (3), stirring, uniformly mixing, and filtering to obtain filtrate, namely the spray for blocking the new coronavirus.
In another aspect, the invention also provides the use of the spray described above for blocking new coronavirus products. Applications of the sprays for blocking new coronaviruses described herein include, but are not limited to, being formulated as sprays or applications.
The application method and mechanism are as follows:
1. the spray for blocking the new coronavirus is made into spray, and is sprayed on clothes, and the mucorales catch the virus in the air, so that the virus protein is rapidly dissolved, the probability of human body infection of the new coronavirus is reduced, the carrying is convenient, and the active protection is realized; the novel coronavirus and other viruses in the air can be captured by being sprayed in vehicles, indoor wall surfaces, schools, hotels, stations, airports and other public places; can also be added in an ultrasonic atomizer for atomization, and is conveyed to public places through a central air conditioner and an air supply pipe of a fresh air system for inactivating viruses.
2. The spray for blocking the new coronavirus is added into a nontoxic water-absorbing resin material, and is made into an application by using a breathable non-woven fabric material and breathable glue, and is attached to a certain part of a body, and nanoscale active mucorales can enter the body through capillary holes to inactivate the new coronavirus in the body and the body.
The invention has the beneficial effects that:
(1) The spray prepared by the method is a nano solvent, has biological activity, can rapidly dissolve viral proteins, rapidly inactivate the novel coronavirus, is harmless to human bodies, and has an inactivation rate of more than 99%; in addition, mucor in the raw materials exists in natural environment and indoor air, and the protein in the prepared spray, application and other products is a temperature bed for growth and propagation of mucor, so that the effective action time of the product is longer.
(2) The invention also discovers that the effect and the action time of inactivating influenza viruses can be obviously enhanced by adjusting the proportion of mucormycosis powder and vitamin E. In addition, the preparation method provided by the invention is simple and easy to operate, and is suitable for industrial mass production.
Detailed Description
In order that the manner in which the above recited features, advantages, objects and advantages of the present invention are obtained will become readily apparent, a more particular description of the invention will be rendered by reference to specific embodiments thereof which are illustrated in the appended drawings. Based on the examples in the embodiments, those skilled in the art can obtain other examples without making any inventive effort, which fall within the scope of the invention.
The experimental methods in the following examples are conventional methods unless otherwise specified, and materials, reagents, etc. used in the following examples are commercially available unless otherwise specified.
Example 1
A spray for blocking new coronavirus and its preparation method are provided:
a spray for blocking new coronaviruses is prepared from the following raw materials: mucor powder 0.1kg, soybean protein powder 70kg, glucose powder 100kg, isomaltooligosaccharide 1kg, vitamin B2.1 kg, vitamin E0.05 kg, fish skin peptide powder 0.05kg, eucommia ulmoides leaf juice 0.1kg and small molecular water 50kg.
The preparation method of the spray comprises the following steps:
1) Taking soybean protein powder according to the weight, steaming, and naturally cooling to room temperature; taking fresh eucommia ulmoides leaves, cleaning, crushing and juicing to obtain eucommia ulmoides leaf juice for later use;
(2) Adding mucor powder into the soybean protein powder obtained in the step (1) according to the weight, uniformly stirring, naturally fermenting for 7 days, crushing into slurry, and filtering;
(3) Taking eucommia ulmoides leaf juice according to the weight, adding the eucommia ulmoides leaf juice into the filtered slurry obtained in the step (2), naturally fermenting for 7 days again, and extracting and purifying at normal temperature to obtain fermentation liquor;
(4) Mixing glucose powder, vitamin B2, vitamin E, isomaltooligosaccharide and fish skin peptide powder according to weight, grinding for 6 hours to 30nm to obtain mixed powder;
(5) Taking small molecular water according to the weight, adding the mixed powder obtained in the step (4) into the small molecular water, uniformly mixing, adding the fermentation broth obtained in the step (3), stirring, uniformly mixing, and filtering to obtain filtrate, namely the spray for blocking the new coronavirus.
Example 2
A spray for blocking new coronavirus and its preparation method are provided:
a spray for blocking new coronaviruses is prepared from the following raw materials: mucor powder 0.4kg, soybean protein powder 80kg, glucose powder 150kg, isomaltooligosaccharide 1.6kg, vitamin B2.2 kg, vitamin E0.1 kg, fish skin peptide powder 0.22kg, eucommia ulmoides leaf juice 0.4kg and small molecule water 58kg. Namely the weight ratio of the mucorales powder to the vitamin E is 4:1.
The preparation method of the spray comprises the following steps:
1) Taking soybean protein powder according to the weight, steaming, and naturally cooling to room temperature; taking fresh eucommia ulmoides leaves, cleaning, crushing and juicing to obtain eucommia ulmoides leaf juice for later use;
(2) Adding mucor powder into the soybean protein powder obtained in the step (1) according to the weight, uniformly stirring, naturally fermenting for 7 days, crushing into slurry, and filtering;
(3) Taking eucommia ulmoides leaf juice according to the weight, adding the eucommia ulmoides leaf juice into the filtered slurry obtained in the step (2), naturally fermenting for 7 days again, and extracting and purifying at normal temperature to obtain fermentation liquor;
(4) Mixing glucose powder, vitamin B2, vitamin E, isomaltooligosaccharide and fish skin peptide powder according to weight, grinding for 8 hours to 20nm to obtain mixed powder;
(5) Taking small molecular water according to the weight, adding the mixed powder obtained in the step (4) into the small molecular water, uniformly mixing, adding the fermentation broth obtained in the step (3), stirring, uniformly mixing, and filtering to obtain filtrate, namely the spray for blocking the new coronavirus.
Example 3
A spray for blocking new coronavirus and its preparation method are provided:
a spray for blocking new coronaviruses is prepared from the following raw materials: mucor powder 0.5kg, soybean protein powder 100kg, glucose powder 200kg, isomaltooligosaccharide 2kg, vitamin B2.3 kg, vitamin E0.2 kg, fish skin peptide powder 0.3kg, eucommia ulmoides leaf juice 0.5kg and small molecular water 60kg.
The preparation method of the spray comprises the following steps:
1) Taking soybean protein powder according to the weight, steaming, and naturally cooling to room temperature; taking fresh eucommia ulmoides leaves, cleaning, crushing and juicing to obtain eucommia ulmoides leaf juice for later use;
(2) Adding mucor powder into the soybean protein powder obtained in the step (1) according to the weight, uniformly stirring, naturally fermenting for 7 days, crushing into slurry, and filtering;
(3) Taking eucommia ulmoides leaf juice according to the weight, adding the eucommia ulmoides leaf juice into the filtered slurry obtained in the step (2), naturally fermenting for 7 days again, and extracting and purifying at normal temperature to obtain fermentation liquor;
(4) Mixing glucose powder, vitamin B2, vitamin E, isomaltooligosaccharide and fish skin peptide powder according to weight, grinding for 7 hours to 25nm to obtain mixed powder;
(5) Taking small molecular water according to the weight, adding the mixed powder obtained in the step (4) into the small molecular water, uniformly mixing, adding the fermentation broth obtained in the step (3), stirring, uniformly mixing, and filtering to obtain filtrate, namely the spray for blocking the new coronavirus.
Example 4
A spray for blocking new coronavirus and its preparation method are provided:
the difference from example 2 is only that the weight ratio of mucor powder to vitamin E is 2:1, i.e. the mucor powder is 0.3kg and the vitamin E is 0.15 kg.
Example 5
A spray for blocking new coronavirus and its preparation method are provided:
the difference from example 2 is only that the weight ratio of mucor powder to vitamin E is 6:1, wherein the weight ratio of mucor powder to vitamin E is 0.48kg and the weight ratio of vitamin E is 0.08 kg.
Comparative example 1
A spray for blocking new coronavirus and its preparation method are provided:
the only difference from example 2 is that no mucor powder was added.
Comparative example 2
A spray for blocking new coronavirus and its preparation method are provided:
the only difference from example 2 is that no vitamin E was added.
Test example 1
The sprays prepared in examples 1-5 and comparative examples 1-2 were subjected to virus inactivation tests.
The test method refers to the virus inactivation test of the 2020 edition-2.1.1.10 of the disinfection technical Specification;
test virus: unmutated new coronavirus strain, new coronavirus D614G variant strain, new coronavirus N501Y variant strain, host cell: vero E6 cells;
test drug concentration: 100 μg/ml, solvent is normal saline; the action time is 2h.
The test results are shown in tables 1-3:
table 1: inhibition of unmutated novel coronaviruses by the present invention
Table 2: the invention has the inhibition effect on the novel coronavirus D614G mutant virus
Table 3: the invention has the inhibition effect on the N501Y mutant virus of the novel coronavirus
Conclusion of the test: the experiment shows that the spray for blocking the new coronavirus obtained by the preparation method provided by the invention can effectively inactivate the new coronavirus, the inactivation rate reaches more than 99%, and cells are not damaged; comparing examples 2,4 and 5 with comparative examples 1,2, it was found that the effect of inactivating chronic influenza virus can be remarkably enhanced by adjusting the ratio of mucorales powder and vitamin E, which have a synergistic effect.
It is to be understood that the above examples are provided for the purpose of clearly illustrating the invention and are not to be construed as limiting the invention in any way. It is intended to enable one skilled in the art to understand the present invention and to practice it accordingly, and is not intended to limit the scope of the present invention. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention as set forth in the claims.
Claims (6)
1. The spray for blocking the novel coronavirus is characterized by being prepared from the following raw materials: mucor powder 0.1-0.5kg, soybean protein powder 70-100kg, glucose powder 100-200kg, isomaltooligosaccharide 1-2kg, vitamin B2.1-0.3 kg, vitamin E0.05-0.2 kg, fish skin peptide powder 0.05-0.3kg, eucommia ulmoides leaf juice 0.1-0.5kg, and small molecular water 50-60kg.
2. The spray of claim 1, wherein the weight ratio of mucorales powder to vitamin E is 2-6:1.
3. The spray of claim 1, wherein the spray is prepared from the following raw materials: mucor powder 0.4kg, soybean protein powder 80kg, glucose powder 150kg, isomaltooligosaccharide 1.6kg, vitamin B2.2 kg, vitamin E0.1 kg, fish skin peptide powder 0.22kg, eucommia ulmoides leaf juice 0.4kg and small molecule water 58kg.
4. The method for preparing the spray according to claim 1, wherein the method comprises the following steps:
(1) Taking soybean protein powder according to the weight, steaming, and naturally cooling to room temperature; taking fresh eucommia ulmoides leaves, cleaning, crushing and juicing to obtain eucommia ulmoides leaf juice for later use;
(2) Adding mucor powder into the soybean protein powder obtained in the step (1) according to the weight, uniformly stirring, naturally fermenting for 7 days, crushing into slurry, and filtering;
(3) Taking eucommia ulmoides leaf juice according to the weight, adding the eucommia ulmoides leaf juice into the filtered slurry obtained in the step (2), naturally fermenting for 7 days again, and extracting and purifying at normal temperature to obtain fermentation liquor;
(4) Mixing glucose powder, vitamin B2, vitamin E, isomaltooligosaccharide and fish skin peptide powder according to weight, grinding for 6-8h to 20-30nm to obtain mixed powder;
(5) Taking small molecular water according to the weight, adding the mixed powder obtained in the step (4) into the small molecular water, uniformly mixing, adding the fermentation broth obtained in the step (3), stirring, uniformly mixing, and filtering to obtain filtrate, namely the spray for blocking the new coronavirus.
5. Use of a spray according to any one of claims 1-3 for blocking a new coronavirus product.
6. The use according to claim 5, wherein the spray is formulated as a spray or an application.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111665386.4A CN116406678A (en) | 2021-12-31 | 2021-12-31 | Spray for blocking new coronavirus, preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111665386.4A CN116406678A (en) | 2021-12-31 | 2021-12-31 | Spray for blocking new coronavirus, preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116406678A true CN116406678A (en) | 2023-07-11 |
Family
ID=87056789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111665386.4A Pending CN116406678A (en) | 2021-12-31 | 2021-12-31 | Spray for blocking new coronavirus, preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116406678A (en) |
-
2021
- 2021-12-31 CN CN202111665386.4A patent/CN116406678A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103989713B (en) | Immunopotentiating composition and its manufacture method | |
CA2152949C (en) | Vaccine preparations | |
KR101467903B1 (en) | The preparing method of immune improving agents | |
CN105087732A (en) | Gastrodia elata polypeptide, preparation method and medical application of gastrodia elata polypeptide in antibiosis and antiviral | |
CN110144333A (en) | One Pseudomonas aeruginosa strain bacteriophage and its application | |
CN113069502A (en) | Toxin-dissolving bionic enzyme and preparation method thereof | |
CN109734810A (en) | Anti- African swine fever virus and CD dual-target pig source antibody, the preparation method and application | |
JP3017630B2 (en) | HIV-type virus activity inhibitor | |
CN116406678A (en) | Spray for blocking new coronavirus, preparation method and application thereof | |
KR100405990B1 (en) | Processs for Preparing Organic Germanium from Cordyceps militaris | |
CN105147589B (en) | A kind of anti-dandruff composition effectively and preparation method thereof | |
CN110280126A (en) | It is a kind of to purify air combined biologically active agents and preparation method thereof | |
JPS58131917A (en) | Agent for counteracting arteriosclerosis | |
TWI257867B (en) | Vaccine preparations containing attenuated toxin | |
CN107376632A (en) | A kind of preparation method for the probiotics for purifying cigar flue gas | |
CN101919878A (en) | Application of coryebactrium parvum in preparing medicament for treating novel A H1N1 influenza viruses | |
CN111991598A (en) | Tibetan incense health-preserving incense string and preparation method thereof | |
WO2006053487A1 (en) | The use of vegetable anthraquinone derivatives and vegetable polysaccharides for treating human immunodeficiency virus (hiv) | |
CN105543258B (en) | A kind of preparation method and its antibacterial applications of Plesiomonas shigelloides bacterial virus catenase | |
CN107899017A (en) | A kind of natural biological nano targeted drug complex material and its preparation method and application | |
RU2248217C2 (en) | Method for preparing immunogenic preparation from yersinia pestis ev | |
CN105106950B (en) | A kind of immunologic adjuvant of live vaccine, preparation method and applications | |
CN111265594A (en) | Medicinal preparation for repairing wound and preparation method thereof | |
JP2000041623A (en) | Production of mycelium essence of pleurotus eryngii | |
CN106562037A (en) | Honeysuckle stem and leaf feed additive for preventing and treating pig intestinal tract infectious diseases and improving feed utilization ratio as well as preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |